Literature DB >> 24173976

The present status of breast reconstruction following mastectomy in the female.

R K Snyderman1.   

Abstract

During the last 10 years increased interest has developed in reconstruction of the female breast following mastectomy. A number of methods of reconstruction are now available. These are immediate reconstruction by means of a silicone implant, delayed reconstruction by means of a silicon implant, use of local flaps with the silicone implant, and use of distant tissue and movement of tissue by microvascular anastomosis.The simplest and most efficient procedure is the one-stage reconstruction which consists of insertion of a silicone prosthesis approximately 6 months following the mastectomy. This can be combined, when necessary, with an elevation and reduction of the remaining breast and the reconstruction at the same time of an areolar and nipple complex.Reconstruction of the female breast in no way jeopardizes the survival of the patients. In addition, it may bring the patient to the surgeon sooner since the knowledge of reconstruction helps to reduce the woman's fear of mutilization.

Entities:  

Year:  1979        PMID: 24173976     DOI: 10.1007/BF01577839

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  2 in total

1.  Editorial: On breast reconstruction after mastectomy for cancer.

Authors:  R Snyderman
Journal:  Plast Reconstr Surg       Date:  1976-02       Impact factor: 4.730

2.  Reconstruction of the female breast following radical mastectomy.

Authors:  R K Snyderman; R H Guthrie
Journal:  Plast Reconstr Surg       Date:  1971-06       Impact factor: 4.730

  2 in total
  2 in total

1.  Reconstruction of the breast after mastectomy for carcinoma.

Authors:  I Prpić
Journal:  Aesthetic Plast Surg       Date:  1981       Impact factor: 2.326

2.  The contralateral breast at reconstructive surgery after breast cancer operation--a histopathological study.

Authors:  A Ringberg; B Palmer; F Linell
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.